Clinical trials
Screening clinical trials
Below are recruiting screening clinical trials, each written for real people, not researchers. We’re tracking 922 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07526545Recruiting
Urine test and MRI for early prostate cancer detection
This study tests a new urine test combined with an MRI to find prostate cancer early. It may help avoid unnecessary biopsies.
Ann Arbor, MichiganAges 50–75 - NCT05733416Recruiting
FDG PET/CT scan after unexplained stroke to find hidden cancer
This study checks whether doing an intensive scan using FDG PET/CT shortly after a “cryptogenic” (unexplained) ischemic stroke can uncover an underlying cause, such as cancer. If a hidden source is found earlier, it may help guide the next treatment steps.
Calgary, AlbertaAges 18 years+ - NCT07612475Enrolling by invitation
Universal type 1 diabetes screening in children
This study helps clinics add a simple blood test to well-child visits to catch type 1 diabetes early, before symptoms appear. It also asks parents and clinic staff for feedback to make screening easier and more routine.
Alexander City, AlabamaAges 1 year+ - NCT07425405Recruiting
Screen time and surgery anxiety in young children
This study looks at how daily screen time affects anxiety in children aged 2 to 5 years before a planned surgery. It aims to find if more screen time is linked to more anxiety, which could help prepare children better for surgery.
Istanbul, küçükçekmeceAges 2–5 - NCT00001727Recruiting
Understanding fibrous dysplasia and McCune-Albright syndrome
This study follows patients with fibrous dysplasia (a condition where normal bone is replaced by fibrous tissue) or McCune-Albright syndrome (a genetic condition affecting bone, skin, and hormones) to understand how these conditions develop and progress over time. There is no experimental treatment; researchers simply want to learn more about these rare conditions.
Bethesda, MarylandAges 1 day–100 years - NCT07177352RecruitingPhase 3
Screening for Roche Alzheimer's studies
This is a screening study to find people who might be eligible for other Alzheimer's drug studies run by the same company. It helps match you to a treatment trial if you qualify.
Birmingham, AlabamaAges 50–90 - NCT02420067Recruiting
Screening for inner-ear tumors in people with Von Hippel-Lindau
This trial focuses on checking whether a specific inner-ear tumor (called an endolymphatic sac tumor) can be found earlier in people with Von Hippel-Lindau (vHL) disease. It may help doctors detect problems sooner so you can discuss treatment options earlier, if needed.
Copenhagen, Copenhagen NAges 15 years+ - NCT04240652Recruiting
Diabetes eye screening and prevention program for eye disease
This program aims to screen people for diabetic eye problems early and help prevent vision loss over time. It may help you if you have type 2 diabetes (or you’ve been invited as a diabetes/non-diabetes participant) and can safely take part in the study activities.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT02800395Recruiting
Study links brain changes to diet and blood markers in Alzheimer’s
This study looks at how diet-related and blood “stress” markers relate to how thinking and memory decline over time in people with Alzheimer’s. It may help researchers find useful biomarkers to better track progression and guide future care.
Pierre-BéniteAges 55 years+ - NCT04931537Recruiting
Testing early kidney marker tests for people with diabetes
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
HangzhouAges 18–80 - NCT04022109Recruiting
Check gastric cancer using breath chemical signals
This study looks at chemical signals in your breath to help screen for or understand gastric (stomach) cancer. It may help doctors improve earlier detection, or better sort out who may need further tests.
São PauloAges 18 years+ - NCT04910802RecruitingPhase 4
HPV vaccine with routine HPV screening for ages 22–26
This study looks at giving the HPV vaccine (Gardasil 9) to women while they go through Sweden’s routine HPV screening. It helps researchers understand how vaccine use alongside screening affects HPV infection and cervical cancer prevention.
StockholmAges 22–27 - NCT05182541Recruiting
Support program for anxious mothers expecting twin babies
This trial tests a psychological screening and nursing (support) approach for pregnant people carrying twins. It may help you if stress, depression, or anxiety symptoms are high, and you want extra support during routine prenatal care.
Shenyang, LiaoningAges 18–50 - NCT05291728Recruiting
Screening for early stomach cancer in Shaanxi
This trial is a community screening program to look for early stomach cancer in adults in Shaanxi. It may help doctors find cancer earlier, when treatment can be more effective.
Xi'an, ShaanxiAges 20 years+ - NCT05361603Recruiting
Screening for hepatitis B, C, and HIV at the same time
This trial tests how acceptable it is for people who use services outside traditional clinics to be screened for hepatitis B, hepatitis C, and HIV during the same visit. If you join, you would be asked to participate and provide consent for the screening process.
Limoges, Haute VienneAges 18 years+ - NCT05391100Recruiting
Screening people with rheumatoid arthritis for lung scarring
This study looks for early lung scarring in people who have rheumatoid arthritis. It may help find a serious lung condition earlier so doctors can watch or treat it sooner.
BudapestAges 40 years+ - NCT05402839Recruiting
Screening people who may be prone to malignant hyperthermia
This study looks at people who had a dangerous anesthesia reaction called malignant hyperthermia during or after surgery. It may help teams figure out who might be at risk in the future so they can take safer steps next time.
Beijing, Beijing MunicipalityAges birth–100 years - NCT05426135Recruiting
AI tool to assess cancer risk and guide care
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Wuhan, HubeiAges 18–75 - NCT05447169Recruiting
Testing blood and DNA checks for nasopharyngeal cancer risk
This study tests an Epstein-Barr virus (EBV) blood antibody and an EBV DNA test to help screen people at higher risk for nasopharyngeal cancer. It may find signs earlier in certain families where cancer runs.
Guangzhou, GuangdongAges 30–62 - NCT05494021Recruiting
Lung cancer screening study for higher-risk adults
This study tests whether people at higher risk for lung cancer can be safely screened using regular chest CT scans. You might benefit from closer monitoring, and the study helps doctors learn the best way to catch lung cancer earlier.
Shanghai, Shanghai MunicipalityAges 45–75 - NCT03308916Recruiting
Screening for liver scarring risk using noninvasive tests
This study checks people who are at higher risk for liver scarring by using noninvasive tests. If those tests suggest significant scarring, the study may consider further testing, but not everyone will need a biopsy.
OdenseAges 30–75 - NCT04603404Recruiting
Imaging tests to find and predict HFpEF risk
This study uses different heart imaging tests to help screen for HFpEF (heart failure with preserved pumping strength), make the diagnosis, and estimate your future risk. You may benefit by getting a clearer diagnosis and a better risk picture based on the scans.
Beijing, Beijing MunicipalityAges Any age - NCT05486455Recruiting
Lung cancer screening CT for eligible former and current smokers
This study looks at how well a chest CT scan can detect lung cancer early in people with a significant smoking history. If you qualify, your CT results may help improve future screening for people like you.
MarseilleAges 50–80 - NCT04904757Recruiting
CESM contrast mammogram screening for dense breasts
This trial tests a newer kind of breast screening scan that uses a special dye (contrast) to better show breast tissue. It may help people with very dense breasts get clearer screening images.
Charlottesville, VirginiaAges 40–69
Hear when a new Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for screening?
- Yes. Clin2 currently lists 922 recruiting screening studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a screening trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a screening trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.